3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
6
Polycystic Ovary Syndrome
2
Obesity
2
Diabetes Mellitus
2
Stroke
1
Sedentary Behavior
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteoporosis
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Kidney Diseases
1
Insulin Resistance
1
Hypertension
1
Heart Failure
1
Frailty
1
Endometrial Neoplasms
1
Diabetes Mellitus, Type 2
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Body Weight
1
Arthritis
1
Interventions
Irinotecan
6
Temozolomide
5
Cyclophosphamide
5
Vincristine
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
palbociclib
3
X-Rays
3
Phantoms, Imaging
3
Gemcitabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
ivosidenib
2
ganitumab
2
eribulin
2
cixutumumab
2
cabozantinib
2
abemaciclib
2
Vemurafenib
2
Specimen Handling
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Peripheral Blood Stem Cell Transplantation
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
FANG vaccine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Ewing
×
Resistance Training
×
Clear all
No trials found.